Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis

This publication has 35 references indexed in Scilit:

• Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin
  Acta Pharmacologica Sinica, 2005
• Activation of phosphoinositide 3-kinase in response to inflammation and nitric oxide leads to the up-regulation of cyclooxygenase-2 expression and subsequent cell proliferation in mesangial cells
  Cellular Signalling, 2005
• Honokiol Induces Apoptosis via Cytochrome c Release and Caspase Activation in Activated Rat Hepatic Stellate Cellsin vitro
  Planta Medica, 2005
• Activation of Phosphoinositide 3-kinase in Response to High Glucose Leads to Regulation of Reactive Oxygen Species-Related Nuclear Factor-κB Activation and Cyclooxygenase-2 Expression in Mesangial Cells
  Molecular Pharmacology, 2004
• Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis
  Kidney International, 1999
• Myocardial Protective Effect of Honokiol: An Active Component inMagnolia ofpcinalis
  Planta Medica, 1996
• Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis.
  Journal of Clinical Investigation, 1994
• Platelet-derived growth factor: A potentially important cytokine in glomerular disease
  Kidney International, 1992
• Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.
  Journal of Clinical Investigation, 1991
• Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell lines
  Biochemical and Biophysical Research Communications, 1991